Peter Fromen - Mar 2, 2022 Form 4 Insider Report for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

Role
Chief Commercial Officer
Signature
/s/ Michele Farmer, Attorney-in-fact
Stock symbol
PACB
Transactions as of
Mar 2, 2022
Transactions value $
$0
Form type
4
Date filed
3/4/2022, 06:26 PM
Previous filing
Jan 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PACB Common Stock Award $0 +50K +35.64% $0.00 190K Mar 2, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PACB Stock Option (right to buy) Award $0 +299K $0.00 299K Mar 2, 2022 Common Stock 299K $11.70 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on March 2 of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.
F2 The shares subject to the option will vest in equal monthly installments over the next four years, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.

Remarks:

Chief Commercial Officer